Valuation: Kenvue Inc.

Market Cap 36.44B 31.85B 29.39B 27.09B 51.05B 3,509B 52.19B 351B 138B 1,719B 137B 134B 5,917B P/E 2026 *
19.9x
P/E 2027 * 17.8x
Enterprise Value 43.85B 38.32B 35.36B 32.59B 61.43B 4,223B 62.79B 423B 166B 2,068B 165B 161B 7,119B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 2.7x
Free-Float
98.9%
Yield 2026 *
4.47%
Yield 2027 * 4.57%
1 day-0.21%
1 week-2.57%
Current month-0.68%
1 month+4.75%
3 months+7.78%
6 months+10.35%
Current year+10.03%
1 week 18.58
Extreme 18.58
19.86
1 month 17.86
Extreme 17.855
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.87
3 years 14.02
Extreme 14.02
25.23
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
6/29/26
Starboard Value LP
OtherCompany 1,413 0.0001%
6/29/26 Free

Director

1,413 0.0001%
6/10/26 Sell

Chief Financial Officer

-3,700 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%-2.57%-13.73%-23.50% 36.44B
-1.00%+2.00%-3.30%+0.48% 349B
+0.92%+1.61%-6.45%+3.44% 135B
-1.16%+0.80%+7.07%+22.60% 74.4B
+2.16%-0.32%-13.89%-20.09% 52.31B
-0.86%-0.64%-5.83%-56.36% 29.71B
+4.09%+1.76%+15.15%-0.04% 19.89B
-0.70%+2.03%-26.11%-31.23% 19.85B
+0.70%+2.76%-1.17%+27.48% 18.43B
+1.34%-1.52%-14.34%+2.87% 11.39B
Average +0.53%+0.59%-6.26%-7.43% 74.7B
Weighted average by Cap. -0.18%+1.28%-4.42%-1.81%

Financials

2026 *2027 *
Net sales 15.63B 13.66B 12.6B 11.61B 21.89B 1,505B 22.38B 151B 59.24B 737B 58.68B 57.39B 2,537B 16.02B 14B 12.92B 11.91B 22.45B 1,543B 22.94B 154B 60.74B 756B 60.17B 58.85B 2,601B
Net income 1.84B 1.61B 1.49B 1.37B 2.58B 177B 2.64B 17.76B 6.99B 86.92B 6.92B 6.77B 299B 2.06B 1.8B 1.67B 1.53B 2.89B 199B 2.96B 19.9B 7.83B 97.38B 7.75B 7.58B 335B
Net Debt 7.41B 6.47B 5.97B 5.51B 10.38B 713B 10.61B 71.39B 28.08B 349B 27.81B 27.2B 1,203B 6.81B 5.95B 5.49B 5.06B 9.54B 656B 9.75B 65.65B 25.82B 321B 25.58B 25.02B 1,106B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-07-17 US$18.98 -0.21% 29,311,427
26-07-16 US$19.02 +1.71% 15,950,710
26-07-15 US$18.70 -0.32% 18,492,278
26-07-14 US$18.76 -2.44% 19,474,126
26-07-13 US$19.23 -1.28% 39,873,974
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.98USD
Average target price
19.75USD
Spread / Average Target
+4.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock